More stringent rules on drug safety

The Central Drugs Standard Controls Organization is putting the details of all its processes online

Zydus acquires derma brand Melgain from Issar Pharma
Veena Mani New Delhi
Last Updated : Oct 06 2016 | 12:59 AM IST
The government is in the process of changing the law to ensure drug manufacturers do not compromise on safety standards.

There is a plan to give manufacturers long-term licences, to instill more accountability. Further, an official stated, the drugs controller will pull up companies for even small mistakes. Recall of drugs that come under safety alerts issued to manufacturers will become mandatory.

At present, recall is voluntary.

Also Read

The source said eight committees had been formed to prepare the details. The final draft should be ready in about six weeks.

The Central Drugs Standard Controls Organization is putting the details of all its processes online. Software is also in the pipeline that will have details of all drugs that received safety alerts from the regulator.

Also, a number of fixed dose combination drugs might be banned, on grounds of irrationality, as recommended by the Kokate committee.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 06 2016 | 12:26 AM IST

Next Story